Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells

• Published in: Cells (Basel, Switzerland) Switzerland), 2023-10, Vol.12 (21), p.2558
• Main Authors: Lu, Jiahe, Veler, Alisa, Simonetti, Boris, Raj, Timsse, Chou, Po Han, Cross, Stephen J, Phillips, Alexander M, Ruan, Xiongtao, Huynh, Lan, Dowsey, Andrew W, Ye, Dingwei, Murphy, Robert F, Verkade, Paul, Cullen, Peter J, Wülfing, Christoph
• Format: Article
• Language: English
• Subjects: Adaptor proteins; Animals; Antibodies; Antigens; Biochemical analysis; Cancer immunotherapy; Carrier Proteins - metabolism; Cell culture; Cell receptors; Cell surface; CTLA-4 Antigen - metabolism; CTLA-4 protein; Distribution; Divergence; Health aspects; imaging; Immunotherapy; inhibitory receptor; Ligands; Localization; Lymphocytes; Lymphocytes T; Mice; Neoplasms - metabolism; Nexin; Pathogens; PD-1 protein; Penicillin; Peptides; Plasmids; Proteomics; proximity proteomics; T cell activation; T cell receptors; T cells; T-Lymphocytes; Therapeutic targets; Transgenic animals; vesicular trafficking
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12212558

T cells can express multiple inhibitory receptors. Upon induction of T cell exhaustion in response to a persistent antigen, prominently in the anti-tumor immune response, many are expressed simultaneously. Key inhibitory receptors are CTLA-4, PD-1, LAG3, TIM3, and TIGIT, as investigated here. These receptors are important as central therapeutic targets in cancer immunotherapy. Inhibitory receptors are not constitutively expressed on the cell surface, but substantial fractions reside in intracellular vesicular structures. It remains unresolved to which extent the subcellular localization of different inhibitory receptors is distinct. Using quantitative imaging of subcellular distributions and plasma membrane insertion as complemented by proximity proteomics and biochemical analysis of the association of the inhibitory receptors with trafficking adaptors, the subcellular distributions of the five inhibitory receptors were discrete. The distribution of CTLA-4 was most distinct, with preferential association with lysosomal-derived vesicles and the sorting nexin 1/2/5/6 transport machinery. With a lack of evidence for the existence of specific vesicle subtypes to explain divergent inhibitory receptor distributions, we suggest that such distributions are driven by divergent trafficking through an overlapping joint set of vesicular structures. This extensive characterization of the subcellular localization of five inhibitory receptors in relation to each other lays the foundation for the molecular investigation of their trafficking and its therapeutic exploitation.